Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v3.24.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
REVENUES $ 5,606 $ 8,831
COST OF REVENUES 3,706 4,721
GROSS PROFIT 1,900 4,110
OPERATING EXPENSES:    
Research and development expenses 2,702 2,766
Sales and marketing expenses, net 3,030 3,282
General and administrative expenses 3,531 4,163
TOTAL OPERATING EXPENSES 9,263 10,211
OPERATING LOSS (7,363) (6,101)
Interest expenses (766) (830)
Other financial income (expenses), net 1,843 (4,051)
Net loss $ (6,286) $ (10,982)
Net loss per share attributable to common shareholders – basic (in Dollars per share) [1],[2] $ (2.61) $ (9.45)
Weighted average number of common stock used in computing net loss per share – basic (in Shares) [1] 2,412,717 1,162,124
[1] Adjusted to reflect reverse stock split, see note 2(ff).
[2] Adjusted to reflect reverse stock split, see note 2(ff).